Ron Paul is asking an interesting question. They are halting the J&J vaccine after a few reactions. Moderna/Pfizer also have many negative reactions, but still going strong. Is there some kind of regulatory preferential treatment of the mRNA variants of the jab?
Ron Paul is asking an interesting question. They are halting the J&J vaccine after a few reactions. Moderna/Pfizer also have many negative reactions, but still going strong. Is there some kind of regulatory preferential treatment of the mRNA variants of the jab?
Yes, because the NIH has co-ownership of the patents for the mRNA vaccines. It's their baby, so to speak.